These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2493524)

  • 1. Effect of glutathione on DNA repair in cisplatin-resistant human ovarian cancer cell lines.
    Lai GM; Ozols RF; Young RC; Hamilton TC
    J Natl Cancer Inst; 1989 Apr; 81(7):535-9. PubMed ID: 2493524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of buthionine sulfoximine on PtII and PtIV drug accumulation and the formation of glutathione conjugates in human ovarian-carcinoma cell lines.
    Mistry P; Loh SY; Kelland LR; Harrap KR
    Int J Cancer; 1993 Nov; 55(5):848-56. PubMed ID: 8244583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circumvention of drug resistance in cisplatin-resistant sublines of the human squamous carcinoma cell line HLac 79 in vitro and in vivo.
    Bier H
    Acta Otolaryngol; 1991; 111(4):797-806. PubMed ID: 1950544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Potentiation of cisplatin sensitivity of cisplatin-resistant human ovarian cancer cell lines by L-buthionine-S,R-sulfoximine].
    Kudoh K; Kita T; Hirata J; Ishii K; Hiramatsu H; Kikuchi Y; Nagata I
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Jun; 46(6):525-32. PubMed ID: 8040625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming tumor necrosis factor-alpha resistance of human renal and ovarian carcinoma cells by combination treatment with buthionine sulfoximine and tumor necrosis factor-alpha. Role of tumor necrosis factor-alpha mRNA down-regulation in tumor cell sensitization.
    Mizutani Y; Yoshida O
    Cancer; 1994 Feb; 73(3):730-7. PubMed ID: 8299097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of buthionine sulfoximine treatment on cellular glutathione levels and cytotoxicities of cisplatin, carboplatin and radiation in human stomach and ovarian cancer cell lines.
    Lee KS; Kim HK; Moon HS; Hong YS; Kang JH; Kim DJ; Park JG
    Korean J Intern Med; 1992 Jul; 7(2):111-7. PubMed ID: 1306072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
    Bertsche U; Schorn H
    Radiat Res; 1986 Mar; 105(3):351-69. PubMed ID: 3754339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anomalous relationship between cisplatin sensitivity and the formation and removal of platinum-DNA adducts in two human ovarian carcinoma cell lines in vitro.
    Shellard SA; Hosking LK; Hill BT
    Cancer Res; 1991 Sep; 51(17):4557-64. PubMed ID: 1873800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of glutathione in resistance to cisplatin in a human small cell lung cancer cell line.
    Meijer C; Mulder NH; Hospers GA; Uges DR; de Vries EG
    Br J Cancer; 1990 Jul; 62(1):72-7. PubMed ID: 2390486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmentation of cisplatin (DDP) cytotoxicity in vivo by DL-buthionine sulfoximine (BSO) in DDP-sensitive and-resistant rat ovarian tumors and its relation to DNA interstrand cross links.
    Chen G; Zeller WJ
    Anticancer Res; 1991; 11(6):2231-7. PubMed ID: 1776864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Schedule dependence of buthionine sulfoximine in reversing resistance to cisplatin.
    Robichaud NJ; Fram RJ
    Chem Biol Interact; 1990; 76(3):333-42. PubMed ID: 2225234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of glutathione (GSH) in determining sensitivity to platinum drugs in vivo in platinum-sensitive and -resistant murine leukaemia and plasmacytoma and human ovarian carcinoma xenografts.
    Goddard P; Valenti M; Kelland LR
    Anticancer Res; 1994; 14(3A):1065-70. PubMed ID: 8074451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Markedly decreased expression of glutathione S-transferase pi gene in human cancer cell lines resistant to buthionine sulfoximine, an inhibitor of cellular glutathione synthesis.
    Yokomizo A; Kohno K; Wada M; Ono M; Morrow CS; Cowan KH; Kuwano M
    J Biol Chem; 1995 Aug; 270(33):19451-7. PubMed ID: 7642628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of cisplatin resistance in acquired-resistant nonsmall cell lung cancer cells.
    Lai SL; Hwang J; Perng RP; Whang-Peng J
    Oncol Res; 1995; 7(1):31-8. PubMed ID: 7549042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship of cellular glutathione to the cytotoxicity and resistance of seven platinum compounds.
    Meijer C; Mulder NH; Timmer-Bosscha H; Sluiter WJ; Meersma GJ; de Vries EG
    Cancer Res; 1992 Dec; 52(24):6885-9. PubMed ID: 1458477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines.
    Masuda H; Ozols RF; Lai GM; Fojo A; Rothenberg M; Hamilton TC
    Cancer Res; 1988 Oct; 48(20):5713-6. PubMed ID: 3139281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single step selection of cis-diamminedichloroplatinum(II) resistant mutants from a human ovarian carcinoma cell line.
    McLaughlin K; Stephens I; McMahon N; Brown R
    Cancer Res; 1991 Apr; 51(8):2242-5. PubMed ID: 1901242
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion.
    Hamilton TC; Winker MA; Louie KG; Batist G; Behrens BC; Tsuruo T; Grotzinger KR; McKoy WM; Young RC; Ozols RF
    Biochem Pharmacol; 1985 Jul; 34(14):2583-6. PubMed ID: 4040369
    [No Abstract]   [Full Text] [Related]  

  • 19. Inhibition of radiation-induced DNA-protein cross-link repair by glutathione depletion with L-buthionine sulfoximine.
    Oleinick NL; Xue LY; Friedman LR; Donahue LL; Biaglow JE
    NCI Monogr; 1988; (6):225-9. PubMed ID: 3352769
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of glutathione in drug resistance.
    Ozols RF; O'Dwyer PJ; Hamilton TC; Young RC
    Cancer Treat Rev; 1990 Dec; 17 Suppl A():45-50. PubMed ID: 2092870
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.